Skip to main content
. 2022 Apr 8;8:34–44. doi: 10.1016/j.jdin.2022.03.013

Table II.

Clinical manifestations of PROD caused by individual PPE components

Clinical manifestation Number of respondents affected (%) Median time (wk) to onset of dermatosis (IQR)
Face mask-related PROD, n 288 -
 Facial itch/rash 122 (42.4) 1 (1, 2)
 Pressure injury (abrasion/pressure sores) 196 (68.1) 1 (1, 2)
 Hyperpigmentation 79 (27.4) 2 (1, 3)
 Acne 206 (71.5) 1 (1, 2)
 Urticaria 16 (5.6) 2 (1, 4)
Protective eyewear-related PROD, n 140 -
 Facial itch/rash 36 (25.7) 1 (1, 2)
 Pressure injury (abrasion/pressure sores) 99 (70.7) 1 (1, 1.25)
Gloves related PROD, n 36 -
 Itch/rash 26 (72.2) 1 (1, 2.75)
 Xerosis 27 (75.0) 1 (1, 2)
 Urticaria 5 (13.9) 1 (1, 1)
Gown related PROD, n 33 -
 Itch/rash 26 (78.8) 1 (1, 3)
 Urticaria 9 (27.3) 1 (1, 2)
Hairnet-related PROD, n 30 -
 Scalp itch 16 (53.3) 2.5 (1.75, 5.5)
 Dandruff 5 (16.7) 4 (3, 10)
 Scalp seborrhea 8 (26.7) 2 (1.75, 3.5)
 Folliculitis 9 (30.0) 2 (2, 5)

PPE, Personal protective equipment; PROD, PPE-related occupational dermatosis.

A total of 307 respondents reported PROD to ≥1 PPE component (ie, face masks, protective eyewear, gloves, gowns, and/or hairnets). 140 (45.6%) respondents reported PROD to 1 PPE component and 121 (39.4%) reported PROD to 2 PPE components. 40 (13.0%) reported PROD to 3 PPE components, 5 (1.6%) reported PROD to 4 PPE components, and 1 (0.3%) reported PROD to all 5 PPE components.